NCM
CMPS

NEXTBio Capital Management’s Compass Pathways CMPS Stock Holding History

NEXTBio Capital Management’s Portfolio CMPS Stock Details CMPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.1M Sell
1,775,759
-245,648
-12% -$2.49M 11.56% 3
2026
Q1 		$11.2M Buy
2,021,407
+1,268,776
+169% +$8.53M 5.19% 5
2025
Q4 		$5.19M Buy
+752,631
New +$4.59M 3.05% 13

Other funds holding CMPS

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

NEXTBio Capital Management's CMPS Position: Q2 2026 in Review

NEXTBio Capital Management reduced its Compass Pathways (CMPS) stake by 12% in Q2 2026, selling an estimated $2.49M and leaving 1,775,759 shares worth $25.1M. The position accounts for 11.56% of the portfolio, ranked #3.

NEXTBio Capital Management first reported a position in CMPS in Q4 2025 and has held it in 3 quarters since. 223 funds tracked by Wall St. Rank hold CMPS as of Q2 2026.

  • NEXTBio Capital Management held 1,775,759 shares of Compass Pathways worth $25.1M as of Q2 2026.
  • NEXTBio Capital Management sold 245,648 Compass Pathways shares in Q2 2026, an estimated $2.49M.
  • Compass Pathways made up 11.56% of NEXTBio Capital Management's portfolio in Q2 2026, its #3 holding.
  • NEXTBio Capital Management first reported a position in Compass Pathways in Q4 2025 and has held it in 3 quarters since.
  • 223 funds tracked by Wall St. Rank held Compass Pathways as of Q2 2026.

Based on NEXTBio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.